Zoetis/$ZTS

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Zoetis

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Ticker

$ZTS

Primary listing

NYSE

Industry

Pharmaceuticals

Employees

13,800

ISIN

US98978V1035

Zoetis Metrics

BasicAdvanced
$70B
28.04
$5.57
0.94
$1.86
1.28%

What the Analysts think about Zoetis

Analyst ratings (Buy, Hold, Sell) for Zoetis stock.

Bulls say / Bears say

Zoetis raised its 2024 profit and revenue forecasts, anticipating adjusted earnings per share between $5.78 and $5.88, driven by strong demand for pet medicines and vaccines. (reuters.com)
BTIG initiated coverage on Zoetis with a 'Buy' rating and a $220 price target, citing the company's robust product portfolio and growth in the animal health market. (investing.com)
Stifel raised its price target for Zoetis to $200, highlighting the company's strong market position and potential for continued growth in the parasiticide segment. (investing.com)
Zoetis' stock reached a 52-week low of $144.53 amid market shifts, reflecting investor concerns over potential challenges in the animal health sector. (investing.com)
The company forecasted 2025 profit and revenue below Wall Street estimates, partly due to a stronger dollar, leading to a 9% drop in shares during premarket trading. (reuters.com)
Zoetis' stock has declined by 11.47% over the past year, indicating potential investor concerns about the company's growth prospects and market conditions. (investing.com)
Data summarised monthly by Lightyear AI. Last updated on 27 Jun 2025.

Zoetis Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Zoetis Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ZTS

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

Jul18
Zoetis
Dividend·Ex-dividend
Sept3
Zoetis
Dividend·Payment
$0.50Per share
FAQs